References

• Demet MM. Obsesif kompulsif bozuklukta genetik çalışmalar. Klinik Psikofarmakoloji Bülteni 2005;15:45–52.
   Google Scholar
• Yaşan A, Gürgen F. Obsesif kompulsif bozuklukta elektroensefalografi bulguları. Klinik Psikofarmakoloji Bülteni 2004; 14:61–67.
   Google Scholar
• Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res 2004;132:69–79.
   PubMed Web of Science ®Google Scholar
• Scarone S, Colombo C, Livian S, Abbruzzese M, Ronchi P, Locatelli M, Scotti G, Smeraldi E. Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging. Psychiatry Res 1992; 45:115–121.
   PubMed Web of Science ®Google Scholar
• Robinson D, Wu H, Munne RA, Ashtari M, Alvir JM, Lerner G, Koreen A, Cole K, Bogerts B. Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry 1995;52:393–398.
   PubMed Web of Science ®Google Scholar
• Szeszko PR, Robinson D, Alvir JM, Bilder RM, Lencz T, Ashtari M, Wu H, Bogerts B. Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry 1999;56:913–919.
   PubMed Web of Science ®Google Scholar
• Jenike MA, Breiter HC, Baer L, Kennedy DN, Savage CR, Olivares MJ, O'Sullivan RL, Shera DM, Rauch SL, Keuthen N, Rosen BR, Caviness VS, Filipek PA. Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry 1996; 53:625–632.
   PubMed Web of Science ®Google Scholar
• O'Sullivan RL, Rauch SL, Breiter HC, Grachev ID, Baer L, Kennedy DN, Keuthen NJ, Savage CR, Manzo PA, Caviness VS, Jenike MA. Reduced basal ganglia volumes in trichotillomania measured via morphometric magnetic resonance imaging. Biol Psychiatry 1997;42:39–45.
   PubMed Web of Science ®Google Scholar
• Bartha R, Stein MB, Williamson PC, Drost DJ, Neufeld RW, Carr TJ, Canaran G, Densmore M, Anderson G, Siddiqui AR. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am J Psychiatry 1998;155:1584–1591.
   PubMed Web of Science ®Google Scholar
• Rosenberg DR, Benazon NR, Gilbert A, Sullivan A, Moore GJ. Thalamic volume in pediatric obsessive—compulsive disorder patients before and after cognitive behavioral therapy. Biol Psychiatry 2000;48:294–300.
   PubMed Web of Science ®Google Scholar
• Riffkin J, Yucel M, Maruff P, Wood SJ, Soulsby B, Olver J, Kyrios M, Velakoulis D, Pantelis C. A manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive-compulsive disorder: comparison with healthy controls and patients with schizophrenia. Psychiatry Res 2005;138:99–113.
   PubMed Web of Science ®Google Scholar
• Atmaca M, Yildirim H, Ozdemi, H, Tezcan E, Poyraz AK. Volumetric MRI study of key brain regions implicated in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:46–52.
   PubMed Web of Science ®Google Scholar
• Atmaca M, Yildirim H, Ozdemir H, Aydin A, Tezcan E, Ozler S. Volumetric MRI assessment of brain regions in patients with refractory obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1051–1057.
   PubMed Web of Science ®Google Scholar
• Tot S, Erdal ME, Yazici K, Yazici AE, Metin O. T102C and—1438 G/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obsessive—compulsive disorder. Eur Psychiatry 2003;18: 249–254.
   Web of Science ®Google Scholar
• Frisch A, Michaelovsky E, Rockah R, Amir I, Hermesh H, Laor N, et al., Association between obsessive compulsive-disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur Neuropsychopharmacol 2000; 10:205–209.
   PubMed Web of Science ®Google Scholar
• Nicolini H, Cruz C, Camarena B, Orozco B, Kennedy JL, King N, Weissbecker K, de la Fuente JR, Sidenberg D. DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Mol Psychiatry 1996;1:461–465.
   PubMed Web of Science ®Google Scholar
• Mundo E, Richter MA, Sam F, Macciardi F, Kennedy JL. Is the 5-HT1Dß Receptor Gene Implicated in the Pathogenesis of Obsessive-Compulsive Disorder? Am J Psychiatry 2000;157:1160–1161.
   Web of Science ®Google Scholar
• Mundo E, Richter MA, Zai G, Sam F, McBride J, Macciardi F, Kennedy JL. 5HT1Dbeta receptor gene implicated in the pathogenesis of obsessive-compulsive disorder: further evidence from a family-based association study. Mol Psychiatry 2002;7:805–809.
   PubMed Web of Science ®Google Scholar
• Camarena B, Nicolini H. Family-based association analysis of 5-HT1Db receptor gene in obsessive-compulsive disorder. Int J Neuropsychopharmacol 2002;5:116.
   Google Scholar
• Corapçıoğlu A, Aydemir O, Yıldız M Esen A, Köroğlu E. DSM-IV Eksen I Bozuklukları (SCID-I) İçin Yapılandırılmış Klinik Görüşme, Klinik Versiyon. Hekimler Yayın Birliği, Ankara 1999.(in Turkish).
   Google Scholar
• Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. The Yale—Brown Obsessive Compulsive Scale II. Validity. Arch Gen Psychiatry 1989;46:1012–1016.
   PubMed Web of Science ®Google Scholar
• Yuh WTC, Tali ET, Afifi AK, Sahinoglu K, Gai F, Bergman RA. MRI of Head & Neck Anatomy, Churchill Livingstone, 1994, New York.
   Google Scholar
• Jackson GD, Duncan JS. MRI Anatomy: A New Angle on the Brain, Churchill Livingstone, 1996, New York.
   Google Scholar
• Patel VH, Friedman L. MRI of the Brain: Normal Anatomy and Normal Variants, WB Saunders Company, 1997. Philadelphia.
   Google Scholar
• Noga JT, Aylward E, Barta PE, Pearlson GD. Cingulate gyrus in schizophrenic patients and normal volunteers. Psychiatry Res 1995;61:201–208.
   PubMed Web of Science ®Google Scholar
• Portas CM, Goldstein JM, Shenton ME, Hokama HH, Wible CG, Fischer I, Kikinis R, Donnino R, Jolesz FA, McCarley RW. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol Psychiatry 1998;43:649–649.
   PubMed Web of Science ®Google Scholar
• Lacerda AL, Nicoletti MA, Brambilla P, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Anatomical MRI study of basal ganglia in major depressive disorder. Psychiatry Res 2003;124:129–140.
   PubMed Web of Science ®Google Scholar
• Sassi RB, Brambilla P, Hatch MA, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Reduced left anterior cingulate volumes in untreated bipolar patients. Biol Psychiatry 2004;56:467–475.
   PubMed Web of Science ®Google Scholar
• Marziniak M, Mössner R, Kienzler C, Riederer P, Lesch KP, Sommer C. Functional polymorphisms of the 5-HT1A and 5-HT1B receptor are associated with clinical symptoms in migraineurs. J Neural Transmission 2007;114:1227–1232.
   Web of Science ®Google Scholar
• Gross R, Sasson Y, Chopra M, Zohar J. Biological models of obsessive-compulsive disorder. The serotonin hypothesis. In: Swinson RP, Antony MM, Rachman S, Richter MA (eds). Obsessive-Compulsive Disorder, Theory, Research and Treatment The Guilford Press: NY, 1998, 147–148.
   Google Scholar
• Stein DJ, Van Heerden B, Wessels CJ, Van Kradenburg J, Warwick J, Wasserman HJ. Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin autoreceptor. Prog Neuropsychopharmacol Biol Psychiatry 1999;23:1079–1099.
   PubMed Web of Science ®Google Scholar
• Koran LM, Pallanti S, Quercioli L. Sumatriptan, 5-HT1D receptors and obsessive-compulsive disorder. Eur Neuropsychopharmacol 2001;11:169–172.
   PubMed Web of Science ®Google Scholar
• Stern L, Zohar J, Cohen R, Sasson Y. Treatment of severe, drug resistant obsessive-compulsive disorder with the 5HT1D agonist sumatriptan. Eur Neuropsychopharmacol 1998;8:325–328.
   PubMed Web of Science ®Google Scholar